 UBBFriend: Email This Page to Someone! |
 Investorville
 G
 Genaissance Pharmaceuticals (GNSC)
|
| next newest topic | next oldest topic |
| Author | Topic: Genaissance Pharmaceuticals (GNSC) |
|
InvestorGuide Daily Administrator |
posted 08-02-2000 06:11 PM
 
Genaissance Pharmaceuticals (GNSC) priced at $13, opened at $15, closed at $16.06, and raised $78 million. |
|
Mayor of Investorville Administrator |
posted 04-24-2000 03:00 PM
The company wants to improve drug discovery and marketing based on population genomics, the analysis of genetic variations within diverse populations. Its HAP Technology is being developed to examine haplotypes, in blood samples. Genaissance plans to market its product to drug developers and makers of drugs already on the market to identify patients most receptive to specific treatments. The company plans to raise $115 million but an IPO date hasn't been set yet. (source: SEC filing) |
All times are EST (US) | next newest topic | next oldest topic |
  |
|
Powered by: Ultimate Bulletin Board, Version 5.43
© Infopop Corporation (formerly Madrona Park, Inc.), 1998 - 2000.
Press ctrl-D to bookmark this page for future reference.
By using this site you agree to our Terms of Use.
Copyright 2001 InvestorGuide.com Inc.